REQUEST A DEMO
Total
USD $0.00
Search more companies

G Nine Bioceuticals Private Limited (India)

Main Activities: Other Business Support Services
Full name: G Nine Bioceuticals Private Limited Profile Updated: March 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

G Nine Bioceuticals Pvt. Ltd is a pharmaceutical formulation company that specializes in manufacturing its own pharmaceutical products and offers third-party manufacturing services. G Nine Bioceuticals Pvt. Ltd operates within the pharmaceutical industry and claims to have served a significant number of customers in the Indian pharmaceutical market over the past decade.

Legal Address
208-F,Sector No.3-A,Hsidc,Industrial Estate
Karnal; Haryana; Postal Code: 132001

Contact Details: Purchase the G Nine Bioceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the G Nine Bioceuticals Private Limited report to view the information.
Registered Capital:
Purchase the G Nine Bioceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the G Nine Bioceuticals Private Limited report to view the information.
Incorporation Date:
August 19, 2008
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after G Nine Bioceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
4.68%
Total operating revenue
4.64%
Operating Profit/Loss (EBIT)
-23.65%
EBITDA
-14.99%
Net Profit/Loss for the Period
-35.5%
Total Assets
23.06%
Total Equity
12.76%
Operating Profit Margin (ROS)
-1.61%
Net Profit Margin
-1.84%
Return on Equity (ROE)
-9.29%
Debt/Equity
-1.11%
Quick Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?